Algeta partners with Avipep - MarketLine Financial Deals

Algeta partners with Avipep

Algeta partners with Avipep - MarketLine Financial Deals
Algeta partners with Avipep
Published Jun 11, 2013
3 pages — Published Jun 11, 2013
Price US$ 20.00  |  Buy this Report Now

About This Report


Algeta ASA has signed a collaboration agreement with Avipep Pty., Ltd. to evaluate a novel targeted thorium conjugate (TTC) based on combining Algeta's proprietary thorium-227 alpha-pharmaceutical payload with an Avibody(TM) from Avipep that targets a number of different solid tumor types.

Document ID
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author

Cite this Report

MarketLine Financial Deals. "Algeta partners with Avipep" Jun 11, 2013. Alacra Store. Jun 23, 2018. <>
MarketLine Financial Deals. (2013). Algeta partners with Avipep Jun 11, 2013. New York, NY: Alacra Store. Retrieved Jun 23, 2018 from <>
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.